Company Name:MacroGenics Inc.
CEO: Scott Koenig

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.


Key numbers

Market Capitalization:422642880
Shares Outstanding: 48917000
Float: 43783160.85
Next Earning Date:2020-02-27
TTm EPS: -3.6055
TTm Dividend Rate:
200 days moving average:15.6
50 days moving average: 10.99
One day percent Change: 5.37



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,